Investigating how a budget program affects costs and care quality for cancer patients receiving chemotherapy
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
This study looks at how a new budget program affects cancer patients getting chemotherapy, focusing on whether it changes the costs and quality of their care, especially for those who might have a harder time accessing treatments.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10928787 on NIH RePORTER |
What this research studies
This research examines the impact of the Global Budget Revenue (GBR) program on cancer patients undergoing chemotherapy. It aims to understand how this budget model influences healthcare costs and the quality of care provided, particularly focusing on potential disparities in access to effective treatments for vulnerable populations. By analyzing data through a difference-in-differences approach, the study seeks to identify both positive and negative outcomes associated with the GBR program, especially regarding its effects on cancer care equity. The findings could inform future healthcare policies and practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients undergoing chemotherapy, particularly those from racial minority groups or with socioeconomic vulnerabilities.
Not a fit: Patients who are not undergoing chemotherapy or those with non-cancer-related health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare policies that enhance access to quality cancer treatment for all patients.
How similar studies have performed: Previous evaluations of similar budget models have shown mixed results, indicating both potential savings and concerns regarding access to care, making this research particularly relevant.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Offodile, Anaeze C — Sloan-Kettering Inst Can Research
- Study coordinator: Offodile, Anaeze C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.